Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Goldman Sachs cuts total voting rights in Gerresheimer to 16.37% from 16.46%

Goldman Sachs cuts total voting rights in Gerresheimer to 16.37% from 16.46%

BitgetBitget2026/10/21 06:47
  • Goldman Sachs cut its total voting rights in Gerresheimer to 16.37% from 16.46%, effective October 13, 2026.
  • Voting rights attached to shares fell to 9.89% from 10.21%; voting rights through instruments rose to 6.48% from 6.25%.
  • The disclosure was published October 21, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gerresheimer AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2418872_en) on October 21, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50

CoreWeave's stock price has dropped nearly 70% from its peak to $54.25, with the short interest ratio rising to 15%. As the AI bubble index reaches an extreme value of 74 and the company faces $3 billion in debt pressure, its share price is at risk of falling below the critical support level of $50.

智通财经•2026/10/26 00:36
AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50

$6 billion acquisition! Medical giant Bausch Health plans to take a controlling stake in Surgery Partners (SGRY.US)

Boston Consulting Group plans to acquire a controlling stake in Surgery Partners for approximately $6 billions, at $20 per share; Bain Capital will retain a 40% stake, and the deal could be announced as early as Monday.

智通财经•2026/10/25 23:41
$6 billion acquisition! Medical giant Bausch Health plans to take a controlling stake in Surgery Partners (SGRY.US)